VolitionRx Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for VolitionRx Limited (VNRX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-27.2635.6730.60-26.8120.76-14.41-18.01
Depreciation & Amortization1.341.411.191.150.720.680.64
Stock Based Compensation1.272.293.115.121.730.000.00
Change in Working Capital-1.2513.7811.02-0.161.760.990.05
Change in Accounts Receivable0.13-0.17-0.07-0.01-0.010.000.00
Change in Accounts Payable-1.221.210.550.542.050.000.00
Change in Other Working Capital-0.160.080.55-0.68-0.580.000.00
Other Operating Activities0.012.293.11-0.181.391.660.02
Net Cash from Operating Activities-25.89-18.06-15.28-20.85-16.46-12.74-14.73
Investing Activities
Capital Expenditures-0.571.08-1.57-0.971.940.51-0.30
Other Investing Activities-0.300.000.000.000.000.000.00
Net Cash from Investing Activities-0.57-1.08-1.57-0.97-1.65-0.51-0.30
Financing Activities
Debt Repayment0.23-1.03-1.31-0.81-0.10-0.35-0.57
Common Stock Issued8.5928.396.7423.2221.2016.5917.25
Common Stock Repurchased0.00-0.03-0.18-0.13-0.240.000.00
Other Financing Activities-0.17-0.20-0.01-0.14-0.1913.430.14
Net Cash from Financing Activities8.6628.986.9422.8620.6230.3617.97
Summary
Effect of Forex Changes on Cash0.340.030.200.11-0.03-0.140.38
Net Change in Cash-17.479.84-9.911.032.4817.112.93
Cash at Beginning of Period20.7310.8720.5819.4416.9713.4310.12
Cash at End of Period3.2620.7310.8720.5819.4430.3913.43
Free Cash Flow-26.47-19.15-16.85-21.83-18.11-13.25-15.03
Supplemental Disclosures
Interest Paid0.340.220.170.160.130.130.11